遵循指南药物推荐以预防既往心肌梗死成年人的动脉粥样硬化性心血管疾病进展。
Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial Infarction.
机构信息
St Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City.
Division of Cardiology, University of Texas Southwestern Medical Center, Dallas.
出版信息
JAMA Netw Open. 2020 Apr 1;3(4):e203032. doi: 10.1001/jamanetworkopen.2020.3032.
Abstract
This cohort study describes the use of drug therapies to prevent the progression of atherosclerotic cardiovascular disease in US patients with prior myocardial infarction and elevated low-density lipoprotein cholesterol levels.
摘要
本队列研究描述了在患有既往心肌梗死和低密度脂蛋白胆固醇水平升高的美国患者中，使用药物治疗来预防动脉粥样硬化性心血管疾病进展的情况。
相似文献
1
Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial Infarction.遵循指南药物推荐以预防既往心肌梗死成年人的动脉粥样硬化性心血管疾病进展。
JAMA Netw Open. 2020 Apr 1;3(4):e203032. doi: 10.1001/jamanetworkopen.2020.3032.
2
Do orders limiting aggressive treatment impact care for acute myocardial infarction?限制积极治疗的医嘱会影响急性心肌梗死的治疗吗？
J Am Med Dir Assoc. 2007 Feb;8(2):91-7. doi: 10.1016/j.jamda.2006.06.004. Epub 2006 Sep 26.
3
Medication non-adherence after myocardial infarction: an exploration of modifying factors.心肌梗死后的药物治疗不依从性：影响因素探究
J Gen Intern Med. 2015 Jan;30(1):83-90. doi: 10.1007/s11606-014-3072-x.
4
How can adherence to guidelines be improved? The case of fibrinolytics.如何提高对指南的依从性？以纤维蛋白溶解剂为例。
Sao Paulo Med J. 2001 Nov 1;119(6):192. doi: 10.1590/s1516-31802001000600002.
5
Repeat prescriptions of guideline-based secondary prevention medication in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care.荷兰初级医疗中2型糖尿病合并既往心肌梗死患者基于指南的二级预防药物重复处方情况
Fam Pract. 2014 Dec;31(6):688-93. doi: 10.1093/fampra/cmu042. Epub 2014 Aug 8.
6
7
Applying the new STEMI guidelines: 2. Disturbances of cardiac rhythm after ST-segment elevation myocardial infarction.应用新的ST段抬高型心肌梗死指南：2. ST段抬高型心肌梗死后的心律失常
CMAJ. 2004 Oct 26;171(9):1042-4. doi: 10.1503/cmaj.1041418.
8
Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017.美国 2013 至 2017 年动脉粥样硬化性心血管疾病成人患者的药物费用相关不依从性。
Circulation. 2019 Dec 17;140(25):2067-2075. doi: 10.1161/CIRCULATIONAHA.119.041974. Epub 2019 Nov 25.
9
Psychological distress and medication adherence: creating order out of chaos?心理困扰与药物依从性：从混乱中创造秩序？
Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):615-6. doi: 10.1161/CIRCOUTCOMES.113.000633. Epub 2013 Nov 12.
10
Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.评估药物依从性对长期心血管结局的影响。
J Am Coll Cardiol. 2016 Aug 23;68(8):789-801. doi: 10.1016/j.jacc.2016.06.005.
引用本文的文献
1
National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020.1999 年至 2020 年，动脉粥样硬化性心血管疾病成人患者接受推荐治疗的种族和民族差异的国家趋势。
JAMA Netw Open. 2023 Dec 1;6(12):e2345964. doi: 10.1001/jamanetworkopen.2023.45964.
2
Use of machine learning to predict medication adherence in individuals at risk for atherosclerotic cardiovascular disease.使用机器学习预测动脉粥样硬化性心血管疾病高危个体的药物依从性。
Smart Health (Amst). 2022 Dec;26. doi: 10.1016/j.smhl.2022.100328. Epub 2022 Oct 4.
3
Lipid-Lowering Therapy Utilization and Dosage Among Patients with Acute Coronary Syndrome Events: A Retrospective Cohort from 12 Community Hospitals.急性冠脉综合征事件患者的降脂治疗使用情况及剂量：来自12家社区医院的回顾性队列研究
Clin Epidemiol. 2023 May 4;15:547-557. doi: 10.2147/CLEP.S400903. eCollection 2023.
4
Inadequate management of cardiovascular risk factors prior to admission for an acute coronary event.急性冠脉事件入院前心血管危险因素管理不足。
J Prev Med Hyg. 2022 Dec 31;63(4):E598-E603. doi: 10.15167/2421-4248/jpmh2022.63.4.2684. eCollection 2022 Dec.
5
Generating Practice-Based Evidence in the Use of Guideline-Recommended Combination Therapy for Secondary Prevention of Acute Myocardial Infarction.在使用指南推荐的联合治疗进行急性心肌梗死二级预防中生成基于实践的证据。
Pharmacy (Basel). 2022 Nov 3;10(6):147. doi: 10.3390/pharmacy10060147.
6
Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research.易损粥样硬化斑块和易损患者概念的演变：对患者治疗和未来研究的影响。
Nat Rev Cardiol. 2023 Mar;20(3):181-196. doi: 10.1038/s41569-022-00769-8. Epub 2022 Sep 23.
7
LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated?低密度脂蛋白胆固醇（LDL-C）：动脉粥样硬化性心血管疾病（ASCVD）唯一的因果风险因素。为何它仍被忽视和低估？
Curr Atheroscler Rep. 2022 Aug;24(8):635-642. doi: 10.1007/s11883-022-01037-3. Epub 2022 May 28.
8
Low-Density Lipoprotein Cholesterol Levels in Coronary Artery Disease Patients: Opportunities for Improvement.冠状动脉疾病患者的低密度脂蛋白胆固醇水平：改善的机会
Cardiol Res Pract. 2022 Apr 27;2022:7537510. doi: 10.1155/2022/7537510. eCollection 2022.
9
Impact of COVID-19 lockdown on lifestyle adherence in stay-at-home patients with chronic coronary syndromes: Towards a time bomb.COVID-19 封锁对居家慢性冠状动脉综合征患者生活方式依从性的影响：一颗定时炸弹。
Int J Cardiol. 2021 Jan 15;323:285-287. doi: 10.1016/j.ijcard.2020.08.094. Epub 2020 Sep 1.
本文引用的文献
1
Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.心肌梗死后（MI）护理：大型真实世界人群中 MI 后二级预防的药物依从性。
Clin Ther. 2019 Jan;41(1):107-117. doi: 10.1016/j.clinthera.2018.11.012. Epub 2018 Dec 24.
2
Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality.医院对二级预防药物的依从率差异及其对质量的影响。
Circulation. 2018 May 15;137(20):2128-2138. doi: 10.1161/CIRCULATIONAHA.117.029160. Epub 2018 Jan 31.
3
Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.急性心肌梗死后二级预防药物的持续使用情况：来自TRANSLATE-ACS研究的见解。
Am Heart J. 2015 Jul;170(1):62-9. doi: 10.1016/j.ahj.2015.03.019. Epub 2015 Apr 2.
4
Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.心肌梗死后二级预防治疗的纵向持续性与患者风险的关系。
Heart. 2015 May 15;101(10):800-7. doi: 10.1136/heartjnl-2014-306754. Epub 2015 Mar 23.
5
Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction.超越药物处方的绩效衡量指标：急性心肌梗死后最佳二级预防药物剂量。
J Am Coll Cardiol. 2013 Nov 5;62(19):1791-801. doi: 10.1016/j.jacc.2013.04.102. Epub 2013 Aug 21.
6
Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care?随着患者风险的变化，心肌梗死指南遵循率的变化：矛盾的治疗结束了吗？
J Am Coll Cardiol. 2011 Oct 18;58(17):1760-5. doi: 10.1016/j.jacc.2011.06.050.
Zotero 插件